Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 144,454 | 145,203 | 232,134 | 351,163 | 383,928 |
| Receivables | 368,348 | 376,760 | 382,308 | 381,792 | 331,429 |
| Inventories | 269,030 | 258,484 | 241,392 | 225,559 | 209,873 |
| Other current assets | 173,823 | 157,590 | 145,392 | 139,284 | 137,508 |
| TOTAL | $955,655 | $938,037 | $1,001,226 | $1,097,798 | $1,062,738 |
| Non-Current Assets | |||||
| PPE Net | 587,667 | 573,385 | 550,255 | 543,963 | 555,167 |
| Intangibles | 458,380 | 94,976 | 450,599 | 296,555 | 52,543 |
| Other Non-Current Assets | 435,501 | 779,346 | 410,069 | 389,069 | 624,113 |
| TOTAL | $1,481,548 | $1,447,707 | $1,410,923 | $1,229,587 | $1,231,823 |
| Total Assets | $2,437,203 | $2,385,744 | $2,412,149 | $2,327,385 | $2,294,561 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 74,996 | 74,990 | 124,982 | 124,971 | 49,988 |
| Accounts payable and accrued liabilities | 116,140 | 86,684 | 93,016 | 87,175 | 74,558 |
| Accrued Expenses | 458,909 | 431,047 | 392,681 | 366,877 | 415,648 |
| TOTAL | $763,579 | $633,849 | $651,809 | $620,662 | $582,761 |
| Non-Current Liabilities | |||||
| Long Term Debt | 775,205 | 778,025 | 780,079 | 778,747 | 858,492 |
| Deferred Revenues | 40,034 | 41,128 | 41,130 | 41,639 | 42,567 |
| Other Non-Current Liabilities | 158,318 | 162,770 | 173,349 | 161,710 | 162,475 |
| TOTAL | $983,632 | $996,435 | $1,012,117 | $1,003,288 | $1,079,005 |
| Total Liabilities | $1,747,211 | $1,630,284 | $1,663,926 | $1,623,950 | $1,661,766 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,249 | 84,794 | 85,076 | 85,281 | 85,426 |
| Common Shares | 10,688 | 10,681 | 10,675 | 10,668 | 10,646 |
| Retained earnings | 2,920,440 | 2,757,669 | 2,582,434 | 2,379,852 | 2,175,595 |
| Other shareholders' equity | -47,456 | -45,703 | -42,299 | -54,171 | -48,295 |
| TOTAL | $689,992 | $755,460 | $748,223 | $703,435 | $632,795 |
| Total Liabilities And Equity | $2,437,203 | $2,385,744 | $2,412,149 | $2,327,385 | $2,294,561 |